Literature DB >> 21062348

Congenital systematized basaloid follicular hamartoma with microphthalmia and hemimegalencephaly.

Valeria Boccaletti1, Patrizia Accorsi, Lorenzo Pinelli, Marco Ungari, Lucio Giordano, Iria Neri, Giuseppe De Panfilis.   

Abstract

The lines of Blaschko are a cutaneous pattern of mosaicism present in a variety of skin disorders. Developmental abnormalities affecting other tissues derived from the embryonic ectoderm and mesoderm are sometimes associated. Here, we describe a 5-year-old boy with basaloid follicular hamartoma affecting the left side of the body in linear multiple bands, following Blaschko lines. Lesions were predominantly hypopigmented macules and streaks, but among these, we could observe brownish atrophic patches and brown papules. Furthermore, ipsilateral hemimegaloencephaly and microphthalmia were present. These findings suggest a neurocutaneous condition recently described by Happle and Tinschert. Its nosologic classification will be discussed.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21062348     DOI: 10.1111/j.1525-1470.2010.01225.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  Happle-Tinschert Syndrome: A Case Report of Unilateral Segmentally Arranged Basaloid Follicular Hamartoma with Scoliosis and Review of Literature.

Authors:  Seong Hoon Seo; Sang Eun Lee; Soo-Chan Kim
Journal:  Ann Dermatol       Date:  2020-03-11       Impact factor: 1.444

2.  Basaloid follicular hamartoma associated with follicular mucinosis and inflammation.

Authors:  Solange Edelman; Adriana Natalia Torres Huamani; María Del Valle Centeno; Andrea Bettina Cervini
Journal:  An Bras Dermatol       Date:  2021-11-14       Impact factor: 1.896

3.  Happle-Tinschert syndrome: report of a case with hemimegalencephaly.

Authors:  Anıl Özgur; Gonca Çabuk; Rabia Arpacı; Kıymet Baz; Demet Katar
Journal:  Korean J Radiol       Date:  2014-07-09       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.